A groundbreaking clinical trial has demonstrated that a custom-designed mRNA vaccine developed by Merck and Moderna substantially lowers the likelihood...
Merck
Merck and Moderna revealed Wednesday that their investigational personalized mRNA cancer vaccine demonstrated efficacy in a substantial phase 3 clinical...